Document is current

Any future updates will be listed below

The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study

Crossref DOI link: https://doi.org/10.1245/s10434-023-14031-z

Published Online: 2023-08-05

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark